A randomized controlled trial for the traditional Chinese medicine comprehensive antihypertensive ABC regimen in the treatment of grade-1 low- and intermediate-risk hypertension

Xiyuan Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Aged between 18-65 years old, male or female;
•(2) Diagnose with grade-1 essential hypertension, and the risk stratification is low-risk or intermediate-risk;
•(3) The diagnosis of TCM syndrome is liver-yang syndrome or asthenic yin causing predominant yang syndrome, or no obvious syndrome;
•(4) Those who have not taken antihypertensive drugs or have taken antihypertensive drugs irregularly, and do not want to take antihypertensive drugs in the next three months;
•(5) Subjects are volunteered to participate in the trial and signed the informed consent.

•(1) Obvious liver and kidney dysfunction. ALT, AST, BUN or creatinine is more than 2 times higher than normal;
•(2) Those who cannot operate Baduanjin or acupoint massage independently;
•(3) Those who have eczema or injury in head, neck or ear, which may be unsuitable for acupoint massage;
•(4) Chronic gastrointestinal diseases;
•(5) Those who may have poor compliance and failure to follow up on time;
•(6) Woman during pregnancy or lactation or those who have a recent birth plan;
•(7) Patients with severe mental illness, malignant tumors or other major diseases;
•(8) Those with a reversed lifestyle or irregular sleep pattern;
•(9) Those who are known or suspected to be allergic to the test drug;
•(10) Those who practice traditional Chinese exercises (such as Taijiquan, Ba Duanjin, etc.) in the past 3 months;
•(11) Those who are inappropriate to participate in this research.

发起方